Discrete Adaptive Responses to MEK Inhibitor in Subpopulations of Triple-Negative Breast CancerDaniel R. Goulet(University of North Carolina at Chapel Hill), Gary L. Johnson(University of Colorado Hospital)Molecular Cancer ResearchAugust 4, 202010.1158/1541-7786.mcr-19-1011Cited by 9SaveCiteExport RISWatch citationsRelated PapersFOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036|npj Breast Cancer|2021|24Comparison of IEC and IEEE Standards for Computer-Based Control Systems Important to Safety|Unknown|2001|9